×
Request Free Sample ×
ReportInfographic

Kindly complete the form below to receive a free sample of this Report

* Please use a valid business email

Leading companies partner with us for data-driven Insights

clients tt-cursor
Hero Background
English
Chinese
French
Japanese
Korean
German
Spanish

Nephrectomy Market Share

ID: MRFR/MED/3913-CR
110 Pages
Kinjoll Dey
December 2019

Nephrectomy Market Research Report Information by Procedure (Open Nephrectomy, Laparoscopic nephrectomy, Robot-assisted Laparoscopic Surgery), Indication (Kidney Cancer and Kidney Disease), End User (Hospitals & Clinics, Surgical Centers) and Region (Americas, Europe, Asia-Pacific and Rest of the World) - Forecast till 2035

Share:
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Nephrectomy Market Infographic
×
Nephrectomy Market Infographic Full View
Request Free Sample
Purchase Options
Compare License
Summary Table of Contents Segmentation Download PDF

Market Share

Nephrectomy Market Share Analysis

The global nephrectomy market has a lot of chances for growth. This is because more people are getting kidney diseases, and governments are making sure that healthcare is more accessible through insurance and reimbursement policies.

One type of nephrectomy called laparoscopy nephrectomy is becoming more popular. This is because it has many benefits. It helps wounds heal quickly, causes less sickness, is less painful, lets patients recover faster, and gives better results compared to other traditional open surgery methods.

Technology is also making laparoscopy better. They are adding 3D technology to laparoscopes, making the pictures clearer and the view wider. In 2014, Leonard and others created a Smart Tissue Anastomosis Robot (STAR) that helped with laparoscopic suturing. With all these improvements, there are big chances for the nephrectomy market to grow in the future.

Now, let's delve deeper into why the nephrectomy market is growing. One major factor is the increasing number of people with kidney diseases. Chronic kidney diseases are becoming more common around the world. This means more people might need nephrectomy procedures, creating a demand for the market.

Moreover, governments are playing a role in this growth. They are implementing policies that make it easier for people to get medical help. With more healthcare insurance coverage and reimbursement policies, individuals can afford treatments like nephrectomy. This, in turn, boosts the demand for these procedures, contributing to the market's expansion.

The specific type of nephrectomy gaining attention is laparoscopy nephrectomy. Over the past decade, its demand has risen significantly. The reasons behind this surge are the numerous advantages it offers. One of the key benefits is fast wound healing. Patients undergoing laparoscopy nephrectomy experience less morbidity, meaning they suffer less from the procedure. The process is also less uncomfortable, and the recovery time is quicker compared to traditional open surgery methods. Additionally, the outcomes of laparoscopy nephrectomy are often better.

In terms of technology, laparoscopy is witnessing remarkable advancements. The incorporation of 3D technologies into laparoscopes has resulted in improved image quality and a broader field of vision for laparoscopic cameras. An interesting development in 2014 was the introduction of the Smart Tissue Anastomosis Robot (STAR) by Leonard et al. This robotic system was vision-guided and designed for laparoscopic suturing. Such technological innovations are expected to fuel the growth of the nephrectomy market in the coming years.

Author
Kinjoll Dey
Research Analyst Level I

He is an extremely curious individual currently working in Healthcare and Medical Devices Domain. Kinjoll is comfortably versed in data centric research backed by healthcare educational background. He leverages extensive data mining and analytics tools such as Primary and Secondary Research, Statistical Analysis, Machine Learning, Data Modelling. His key role also involves Technical Sales Support, Client Interaction and Project management within the Healthcare team. Lastly, he showcases extensive affinity towards learning new skills and remain fascinated in implementing them.

Get In Touch

Leave a Comment

FAQs

At what CAGR is the nephrectomy market projected to grow in the forecast period (2023-2032)?

Nephrectomy market is projected grow at approximately 4.2% CAGR during the assessment period (2023-2032).

What was the value of the nephrectomy market in 2032?

The valuation of the nephrectomy market had reached USD 5.71 Billion in 2032.

Which is the major segment in the nephrectomy market?

The corticosteroid lotions segment by treatment type holds the majority shares in the nephrectomy market.

Which region holds the largest share in the nephrectomy market?

North America holds the largest share in the nephrectomy market, followed by Europe and the Asia Pacific, respectively.

Who are the top players in the nephrectomy market?

Olympus Corporation (Japan), KARL STORZ SE & Co. KG (Germany)., Medtronic Plc (Ireland), Johnson & Johnson Services Inc. (US), B. Braun Melsungen AG (Germany), Cook Group (US), XCELLANCE Medical Technologies (India), and CONMED Corporation (US), are some of the major players operating in the global nephrectomy market.

Which region holds the latest share in the Nephrectomy Market?

North America holds the largest share in the Nephrectomy Market, which is followed by Europe and the Asia Pacific respectively.

Market Summary

As per MRFR analysis, the Nephrectomy Market Size was estimated at 3315.7 USD Million in 2024. The Nephrectomy industry is projected to grow from 3598.72 USD Million in 2025 to 7295.26 USD Million by 2035, exhibiting a compound annual growth rate (CAGR) of 7.39 during the forecast period 2025 - 2035.

Key Market Trends & Highlights

The Nephrectomy Market is experiencing a transformative shift towards advanced surgical techniques and patient-centric approaches.

  • The rise of minimally invasive techniques is reshaping surgical practices in nephrectomy, particularly in North America.
  • Patient-centered care is becoming increasingly emphasized, reflecting a broader trend in healthcare delivery across the Asia-Pacific region.
  • Laparoscopic nephrectomy remains the largest segment, while robotic-assisted nephrectomy is emerging as the fastest-growing segment in surgical interventions.
  • The increasing incidence of kidney diseases and technological advancements in surgical techniques are driving market growth significantly.

Market Size & Forecast

2024 Market Size 3315.7 (USD Million)
2035 Market Size 7295.26 (USD Million)
CAGR (2025 - 2035) 7.39%
Largest Regional Market Share in 2024 North America

Major Players

Medtronic (US), Johnson & Johnson (US), Baxter International (US), Boston Scientific (US), Stryker (US), Abbott Laboratories (US), Terumo Corporation (JP), Fresenius Medical Care (DE), Smith & Nephew (GB)

Market Trends

The Nephrectomy Market is currently experiencing a notable evolution, driven by advancements in surgical techniques and technologies. Minimally invasive procedures are gaining traction, as they offer patients reduced recovery times and lower complication rates. This shift towards less invasive methods appears to be reshaping the landscape of nephrectomy, as healthcare providers increasingly adopt robotic-assisted surgeries and laparoscopic approaches. Furthermore, the growing prevalence of kidney diseases and the rising incidence of renal cancers are likely to fuel demand for nephrectomy procedures, indicating a robust market trajectory. In addition to technological advancements, the Nephrectomy Market is influenced by the increasing focus on patient-centered care. Healthcare systems are prioritizing outcomes that enhance the quality of life for patients undergoing nephrectomy. This trend suggests a potential shift towards personalized treatment plans, where the choice of surgical method may be tailored to individual patient needs. Moreover, ongoing research and development efforts in the field of nephrology are expected to yield innovative solutions, further propelling the market forward. As the landscape continues to evolve, stakeholders must remain vigilant to adapt to these emerging trends and capitalize on the opportunities they present.

Rise of Minimally Invasive Techniques

The Nephrectomy Market is witnessing a significant shift towards minimally invasive surgical techniques. These methods, including laparoscopic and robotic-assisted surgeries, are preferred due to their potential for reduced recovery times and lower complication rates. As healthcare providers increasingly adopt these approaches, the overall patient experience is likely to improve, driving further interest in nephrectomy procedures.

Emphasis on Patient-Centered Care

There is a growing emphasis on patient-centered care within the Nephrectomy Market. Healthcare systems are focusing on enhancing the quality of life for patients undergoing nephrectomy, which may lead to more personalized treatment plans. This trend indicates a potential shift in how surgical options are presented, with a greater consideration for individual patient needs and preferences.

Innovations in Nephrology Research

Ongoing research and development in nephrology are expected to yield innovative solutions that could transform the Nephrectomy Market. Advances in understanding kidney diseases and renal cancers may lead to new surgical techniques and improved patient outcomes. As these innovations emerge, they are likely to create new opportunities for stakeholders in the nephrectomy field.

Nephrectomy Market Market Drivers

Increasing Healthcare Expenditure

Rising healthcare expenditure across various regions is positively impacting the Global Nephrectomy Market Industry. Governments and private sectors are investing more in healthcare infrastructure, leading to improved access to surgical procedures, including nephrectomy. Enhanced funding allows for better facilities, advanced technologies, and skilled healthcare professionals, which collectively contribute to higher surgical volumes. As healthcare spending continues to grow, the market is poised for expansion, aligning with the overall trends in healthcare investment and patient care.

Rising Incidence of Kidney Diseases

The increasing prevalence of kidney diseases globally is a primary driver of the Global Nephrectomy Market Industry. Conditions such as chronic kidney disease and renal cell carcinoma are on the rise, necessitating surgical interventions like nephrectomy. According to health statistics, the incidence of kidney cancer has been steadily increasing, with projections indicating that by 2024, the market could reach 3.46 USD Billion. This growing patient population underscores the need for effective surgical solutions, thereby propelling the demand for nephrectomy procedures and related technologies.

Growing Awareness and Screening Programs

Increased awareness regarding kidney health and the importance of early detection is contributing to the growth of the Global Nephrectomy Market Industry. Public health initiatives and screening programs aimed at identifying kidney diseases at earlier stages are becoming more prevalent. These efforts are likely to lead to higher rates of diagnosis and, consequently, a greater number of nephrectomy procedures. As healthcare systems worldwide prioritize preventive measures, the market is expected to expand, aligning with the projected CAGR of 5.85% from 2025 to 2035, indicating a robust growth trajectory.

Aging Population and Associated Health Issues

The aging population is a significant factor driving the Global Nephrectomy Market Industry. As individuals age, the risk of developing kidney-related ailments increases, leading to a higher demand for nephrectomy procedures. The demographic shift towards an older population is evident globally, with projections indicating that by 2035, a substantial portion of the population will be over 65 years old. This demographic trend is likely to result in an increased incidence of kidney diseases, thereby fueling the demand for nephrectomy and related healthcare services.

Technological Advancements in Surgical Techniques

Innovations in surgical techniques and technologies are significantly influencing the Global Nephrectomy Market Industry. Minimally invasive procedures, such as laparoscopic nephrectomy, have gained traction due to their benefits, including reduced recovery times and lower complication rates. These advancements not only enhance surgical outcomes but also attract more patients seeking nephrectomy. As the industry evolves, the integration of robotic-assisted surgeries is expected to further drive market growth. The anticipated market size of 6.46 USD Billion by 2035 reflects the impact of these technological improvements on surgical practices.

Market Segment Insights

By Procedure Type: Laparoscopic Nephrectomy (Largest) vs. Robotic-Assisted Nephrectomy (Fastest-Growing)

In the Nephrectomy Market, Laparoscopic Nephrectomy holds the largest market share, reflecting a shift towards minimally invasive surgical techniques. Open Nephrectomy, while still significant, has seen a decline in preference due to its more invasive nature and longer recovery times. Partial Nephrectomy is gaining traction as well, particularly due to heightened awareness about organ preservation and improvements in surgical techniques. The growth trends within the Nephrectomy Market are primarily driven by advancements in minimally invasive procedures, with Robotic-Assisted Nephrectomy emerging rapidly in response to increased demand for precision surgical methods. The enhanced recovery protocols associated with Laparoscopic and Robotic-Assisted techniques provide compelling benefits over traditional methods, leading to higher adoption rates among both surgeons and patients.

Laparoscopic Nephrectomy (Dominant) vs. Partial Nephrectomy (Emerging)

Laparoscopic Nephrectomy is currently viewed as the dominant procedure in the Nephrectomy market, thanks to its various advantages, including shorter hospital stays, reduced postoperative pain, and quicker recovery times. This procedure minimizes the patient's trauma due to smaller incisions, leading to lesser scarring and complications. In contrast, Partial Nephrectomy is emerging as a preferred option for suitable cases focused on kidney preservation. This technique aligns with the growing trend of organ-sparing surgeries, attracting patients who wish to maintain as much kidney function as possible. Both approaches are redefining surgical practices within the nephrology domain, responding to the evolving needs of patients and healthcare providers.

By Indication: Renal Cell Carcinoma (Largest) vs. Kidney Stones (Fastest-Growing)

In the Nephrectomy Market, Renal Cell Carcinoma is currently the largest segment, accounting for a significant share of procedures. Following closely is the Kidney Stones segment, which is positioned as the fastest-growing area within the market. As healthcare providers increasingly recognize the need for specialized procedures, this segment has gained traction in recent years, particularly in regions where kidney stone cases are prevalent. Other segments like Polycystic Kidney Disease and Trauma are also included but occupy a smaller portion of the overall market share.

Renal Cell Carcinoma: Dominant vs. Kidney Stones: Emerging

Renal Cell Carcinoma remains the dominant indication for nephrectomy procedures due to its high prevalence and the necessity for surgical intervention. This segment benefits from advancements in technology and surgical techniques, which enhance patient outcomes. Conversely, the Kidney Stones segment is emerging rapidly, driven by a rising incidence of stone formation attributed to lifestyle changes and dietary factors. Increased awareness and proactive healthcare initiatives are leading to more patients seeking treatment for kidney stones, thereby propelling growth. Both segments are influenced by ongoing research and development, impacting their respective market trajectories.

By End User: Hospitals (Largest) vs. Ambulatory Surgical Centers (Fastest-Growing)

In the nephrectomy market, hospitals represent the largest segment, capturing a significant share due to their advanced surgical capabilities and comprehensive care facilities. They typically have the infrastructure to conduct complex procedures and manage postoperative care effectively, leading to their favorable position. On the other hand, ambulatory surgical centers are emerging rapidly, meeting the increasing demand for outpatient procedures and offering convenience and cost-effectiveness. As surgical techniques advance, a portion of nephrectomy procedures are transitioning to these centers, increasing their market presence.

Hospitals (Dominant) vs. Specialty Clinics (Emerging)

Hospitals hold a dominant position in the nephrectomy market, primarily due to their ability to provide multidisciplinary approaches and access to advanced technology. These institutions are equipped with state-of-the-art operating rooms and recovery facilities, enabling them to handle a wide variety of nephrectomy cases including complex ones with higher risk factors. In contrast, specialty clinics are seen as emerging players, focusing on minimally invasive techniques which appeal to patients seeking quicker recovery times and lower costs. While still smaller in comparison to hospitals, specialty clinics are carving a niche, particularly in outpatient nephrectomy procedures, thereby driving innovation and patient-centric services in the market.

By Surgical Approach: Minimally Invasive Surgery (Largest) vs. Traditional Surgery (Fastest-Growing)

The nephrectomy market has shown that minimally invasive surgery holds the largest share among surgical approaches, reflecting the growing preference for less invasive procedures. Traditional surgery, while still important, is being overshadowed by advancements and patient demands for quicker recovery times, leading to a notable shift in market dynamics. As technologies improve, the appeal of minimally invasive methods continues to rise, making it a primary choice for both patients and healthcare providers. Growth trends in the nephrectomy market indicate a robust increase in minimally invasive surgery, driven by technological advancements such as robotic-assisted surgery and enhanced imaging techniques. On the other hand, traditional surgery, though experiencing slower growth, remains essential for complex cases where other methods may not be feasible. The accessibility of advanced training for surgeons in minimally invasive techniques and a shift towards outpatient procedures are major drivers of this segment's expansion.

Minimally Invasive Surgery (Dominant) vs. Traditional Surgery (Emerging)

Minimally invasive surgery has emerged as the dominant force in the nephrectomy market due to its numerous benefits, including reduced hospital stays and quicker recovery times. Patients favor this approach as it typically involves smaller incisions, resulting in less postoperative pain and a lower risk of complications. Traditional surgery, while still vital, is now viewed as an emerging option reserved for complex cases where minimally invasive methods may not suffice. Surgeons are increasingly trained in advanced techniques, leading to improved outcomes and higher patient satisfaction rates for minimally invasive procedures. The growing emphasis on patient-centered care and improved surgical outcomes continues to position minimally invasive surgery as the preferred choice in nephrectomy.

Get more detailed insights about Nephrectomy Market Research Report - Forecast till 2035

Regional Insights

North America : Market Leader in Nephrectomy

North America continues to lead the nephrectomy market, holding a significant share of 1656.28M in 2024. The region's growth is driven by advanced healthcare infrastructure, increasing prevalence of kidney diseases, and a rising demand for minimally invasive surgical procedures. Regulatory support and innovation in surgical technologies further enhance market dynamics, making it a hub for nephrectomy advancements. The competitive landscape in North America is robust, featuring key players such as Medtronic, Johnson & Johnson, and Baxter International. These companies are at the forefront of developing innovative solutions that cater to the growing demand for nephrectomy procedures. The U.S. remains the largest market, supported by a high volume of surgeries and a strong focus on research and development in surgical techniques.

Europe : Emerging Market with Growth Potential

Europe's nephrectomy market is valued at 1000.0M, showcasing a growing demand driven by an aging population and increasing awareness of kidney health. Regulatory frameworks across the EU are evolving to support innovative surgical techniques, which is expected to further boost market growth. The region is witnessing a shift towards outpatient procedures, enhancing patient recovery times and reducing healthcare costs. Leading countries in this market include Germany, France, and the UK, where healthcare systems are increasingly adopting advanced nephrectomy technologies. Major players like Fresenius Medical Care and Smith & Nephew are actively involved in expanding their product offerings. The competitive landscape is characterized by collaborations and partnerships aimed at enhancing surgical outcomes and patient care.

Asia-Pacific : Rapidly Growing Healthcare Sector

The Asia-Pacific nephrectomy market, valued at 550.0M, is experiencing rapid growth due to rising healthcare expenditures and increasing incidences of kidney-related diseases. Countries like China and India are investing heavily in healthcare infrastructure, which is expected to drive demand for nephrectomy procedures. Regulatory bodies are also promoting advanced surgical techniques, contributing to market expansion. China and Japan are leading the market, with significant contributions from local and international players. Companies such as Terumo Corporation are focusing on innovative solutions tailored to regional needs. The competitive landscape is evolving, with a growing emphasis on minimally invasive techniques and patient-centric care, positioning Asia-Pacific as a key player in The Nephrectomy.

Middle East and Africa : Emerging Market with Challenges

The Middle East and Africa nephrectomy market, valued at 109.42M, is gradually emerging, driven by increasing healthcare investments and a rising prevalence of kidney diseases. However, challenges such as limited access to advanced medical technologies and varying healthcare standards across countries hinder rapid growth. Regulatory bodies are working to improve healthcare infrastructure, which is essential for market development. Countries like South Africa and the UAE are leading the market, with a focus on enhancing surgical capabilities. The presence of key players is growing, but the market remains fragmented. Local partnerships and collaborations are crucial for improving access to nephrectomy procedures and advancing healthcare delivery in the region.

Key Players and Competitive Insights

The Nephrectomy Market is characterized by a dynamic competitive landscape, driven by advancements in surgical techniques, increasing prevalence of kidney diseases, and a growing demand for minimally invasive procedures. Key players such as Medtronic (US), Johnson & Johnson (US), and Baxter International (US) are strategically positioned to leverage innovation and technological advancements. Medtronic (US) focuses on enhancing its robotic-assisted surgical systems, while Johnson & Johnson (US) emphasizes its comprehensive portfolio of surgical instruments and devices. Baxter International (US) is actively pursuing partnerships to expand its renal care solutions, thereby shaping a competitive environment that prioritizes innovation and patient outcomes.The market structure appears moderately fragmented, with several players vying for market share through localized manufacturing and optimized supply chains. Companies are increasingly localizing their production to reduce costs and improve responsiveness to regional demands. This strategy not only enhances operational efficiency but also allows for better alignment with local regulatory requirements, thereby influencing the competitive dynamics of the market.

In November Medtronic (US) announced the launch of its latest robotic-assisted nephrectomy system, which integrates advanced imaging technology to enhance surgical precision. This strategic move is likely to position Medtronic (US) as a leader in the minimally invasive surgery segment, potentially increasing its market share and reinforcing its commitment to innovation in surgical solutions. The introduction of this system may also catalyze further advancements in robotic surgery, influencing competitors to enhance their offerings.

In October Johnson & Johnson (US) expanded its partnership with a leading healthcare provider to enhance training programs for surgeons utilizing its nephrectomy devices. This initiative underscores the company's focus on education and support, which is crucial for the successful adoption of new technologies. By investing in surgeon training, Johnson & Johnson (US) not only strengthens its market position but also fosters a community of skilled practitioners who can effectively utilize its products, thereby enhancing patient outcomes.

In September Baxter International (US) entered into a strategic alliance with a biotechnology firm to develop innovative renal therapies aimed at improving post-operative recovery for nephrectomy patients. This collaboration highlights Baxter's commitment to expanding its renal care portfolio and addressing unmet needs in patient recovery. Such strategic alliances are indicative of a broader trend where companies are seeking to combine expertise to drive innovation and improve patient care in the nephrectomy space.

As of December the Nephrectomy Market is witnessing trends such as digitalization, sustainability, and the integration of artificial intelligence (AI) into surgical practices. These trends are reshaping the competitive landscape, with companies increasingly focusing on strategic alliances to enhance their technological capabilities. The shift from price-based competition to a focus on innovation, technology, and supply chain reliability is becoming evident. As the market evolves, differentiation will likely hinge on the ability to deliver advanced surgical solutions that improve patient outcomes and operational efficiencies.

Key Companies in the Nephrectomy Market include

Industry Developments

The Americas accounts for the largest share in the global Market.

Future Outlook

Nephrectomy Market Future Outlook

The Nephrectomy Market is projected to grow at a 7.39% CAGR from 2025 to 2035, driven by technological advancements, increasing prevalence of kidney diseases, and rising healthcare expenditure.

New opportunities lie in:

  • Development of minimally invasive nephrectomy devices
  • Expansion of telehealth services for pre- and post-operative care
  • Investment in AI-driven surgical planning software

By 2035, the Nephrectomy Market is expected to achieve substantial growth and innovation.

Market Segmentation

Nephrectomy Market End User Outlook

  • Hospitals
  • Ambulatory Surgical Centers
  • Specialty Clinics

Nephrectomy Market Indication Outlook

  • Renal Cell Carcinoma
  • Kidney Stones
  • Polycystic Kidney Disease
  • Trauma

Nephrectomy Market Procedure Type Outlook

  • Open Nephrectomy
  • Laparoscopic Nephrectomy
  • Robotic-Assisted Nephrectomy
  • Partial Nephrectomy

Nephrectomy Market Surgical Approach Outlook

  • Minimally Invasive Surgery
  • Traditional Surgery
  • Transplant Surgery

Report Scope

MARKET SIZE 20243315.7(USD Million)
MARKET SIZE 20253598.72(USD Million)
MARKET SIZE 20357295.26(USD Million)
COMPOUND ANNUAL GROWTH RATE (CAGR)7.39% (2025 - 2035)
REPORT COVERAGERevenue Forecast, Competitive Landscape, Growth Factors, and Trends
BASE YEAR2024
Market Forecast Period2025 - 2035
Historical Data2019 - 2024
Market Forecast UnitsUSD Million
Key Companies ProfiledMedtronic (US), Johnson & Johnson (US), Baxter International (US), Boston Scientific (US), Stryker (US), Abbott Laboratories (US), Terumo Corporation (JP), Fresenius Medical Care (DE), Smith & Nephew (GB)
Segments CoveredProcedure Type, Indication, End User, Surgical Approach
Key Market OpportunitiesAdvancements in minimally invasive techniques enhance patient outcomes in the Nephrectomy Market.
Key Market DynamicsTechnological advancements and regulatory changes are reshaping the competitive landscape of the nephrectomy market.
Countries CoveredNorth America, Europe, APAC, South America, MEA

FAQs

At what CAGR is the nephrectomy market projected to grow in the forecast period (2023-2032)?

Nephrectomy market is projected grow at approximately 4.2% CAGR during the assessment period (2023-2032).

What was the value of the nephrectomy market in 2032?

The valuation of the nephrectomy market had reached USD 5.71 Billion in 2032.

Which is the major segment in the nephrectomy market?

The corticosteroid lotions segment by treatment type holds the majority shares in the nephrectomy market.

Which region holds the largest share in the nephrectomy market?

North America holds the largest share in the nephrectomy market, followed by Europe and the Asia Pacific, respectively.

Who are the top players in the nephrectomy market?

Olympus Corporation (Japan), KARL STORZ SE & Co. KG (Germany)., Medtronic Plc (Ireland), Johnson & Johnson Services Inc. (US), B. Braun Melsungen AG (Germany), Cook Group (US), XCELLANCE Medical Technologies (India), and CONMED Corporation (US), are some of the major players operating in the global nephrectomy market.

Which region holds the latest share in the Nephrectomy Market?

North America holds the largest share in the Nephrectomy Market, which is followed by Europe and the Asia Pacific respectively.

  1. SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
    1. | 1.1 EXECUTIVE SUMMARY
    2. | 1.1.1 Market Overview
    3. | 1.1.2 Key Findings
    4. | 1.1.3 Market Segmentation
    5. | 1.1.4 Competitive Landscape
    6. | 1.1.5 Challenges and Opportunities
    7. | 1.1.6 Future Outlook
  2. SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
    1. | 2.1 MARKET INTRODUCTION
    2. | 2.1.1 Definition
    3. | 2.1.2 Scope of the study
    4. |-- 2.1.2.1 Research Objective
    5. |-- 2.1.2.2 Assumption
    6. |-- 2.1.2.3 Limitations
    7. | 2.2 RESEARCH METHODOLOGY
    8. | 2.2.1 Overview
    9. | 2.2.2 Data Mining
    10. | 2.2.3 Secondary Research
    11. | 2.2.4 Primary Research
    12. |-- 2.2.4.1 Primary Interviews and Information Gathering Process
    13. |-- 2.2.4.2 Breakdown of Primary Respondents
    14. | 2.2.5 Forecasting Model
    15. | 2.2.6 Market Size Estimation
    16. |-- 2.2.6.1 Bottom-Up Approach
    17. |-- 2.2.6.2 Top-Down Approach
    18. | 2.2.7 Data Triangulation
    19. | 2.2.8 Validation
  3. SECTION III: QUALITATIVE ANALYSIS
    1. | 3.1 MARKET DYNAMICS
    2. | 3.1.1 Overview
    3. | 3.1.2 Drivers
    4. | 3.1.3 Restraints
    5. | 3.1.4 Opportunities
    6. | 3.2 MARKET FACTOR ANALYSIS
    7. | 3.2.1 Value chain Analysis
    8. | 3.2.2 Porter's Five Forces Analysis
    9. |-- 3.2.2.1 Bargaining Power of Suppliers
    10. |-- 3.2.2.2 Bargaining Power of Buyers
    11. |-- 3.2.2.3 Threat of New Entrants
    12. |-- 3.2.2.4 Threat of Substitutes
    13. |-- 3.2.2.5 Intensity of Rivalry
    14. | 3.2.3 COVID-19 Impact Analysis
    15. |-- 3.2.3.1 Market Impact Analysis
    16. |-- 3.2.3.2 Regional Impact
    17. |-- 3.2.3.3 Opportunity and Threat Analysis
  4. SECTION IV: QUANTITATIVE ANALYSIS
    1. | 4.1 Healthcare, BY Procedure Type (USD Million)
    2. | 4.1.1 Open Nephrectomy
    3. | 4.1.2 Laparoscopic Nephrectomy
    4. | 4.1.3 Robotic-Assisted Nephrectomy
    5. | 4.1.4 Partial Nephrectomy
    6. | 4.2 Healthcare, BY Indication (USD Million)
    7. | 4.2.1 Renal Cell Carcinoma
    8. | 4.2.2 Kidney Stones
    9. | 4.2.3 Polycystic Kidney Disease
    10. | 4.2.4 Trauma
    11. | 4.3 Healthcare, BY End User (USD Million)
    12. | 4.3.1 Hospitals
    13. | 4.3.2 Ambulatory Surgical Centers
    14. | 4.3.3 Specialty Clinics
    15. | 4.4 Healthcare, BY Surgical Approach (USD Million)
    16. | 4.4.1 Minimally Invasive Surgery
    17. | 4.4.2 Traditional Surgery
    18. | 4.4.3 Transplant Surgery
    19. | 4.5 Healthcare, BY Region (USD Million)
    20. | 4.5.1 North America
    21. |-- 4.5.1.1 US
    22. |-- 4.5.1.2 Canada
    23. | 4.5.2 Europe
    24. |-- 4.5.2.1 Germany
    25. |-- 4.5.2.2 UK
    26. |-- 4.5.2.3 France
    27. |-- 4.5.2.4 Russia
    28. |-- 4.5.2.5 Italy
    29. |-- 4.5.2.6 Spain
    30. |-- 4.5.2.7 Rest of Europe
    31. | 4.5.3 APAC
    32. |-- 4.5.3.1 China
    33. |-- 4.5.3.2 India
    34. |-- 4.5.3.3 Japan
    35. |-- 4.5.3.4 South Korea
    36. |-- 4.5.3.5 Malaysia
    37. |-- 4.5.3.6 Thailand
    38. |-- 4.5.3.7 Indonesia
    39. |-- 4.5.3.8 Rest of APAC
    40. | 4.5.4 South America
    41. |-- 4.5.4.1 Brazil
    42. |-- 4.5.4.2 Mexico
    43. |-- 4.5.4.3 Argentina
    44. |-- 4.5.4.4 Rest of South America
    45. | 4.5.5 MEA
    46. |-- 4.5.5.1 GCC Countries
    47. |-- 4.5.5.2 South Africa
    48. |-- 4.5.5.3 Rest of MEA
  5. SECTION V: COMPETITIVE ANALYSIS
    1. | 5.1 Competitive Landscape
    2. | 5.1.1 Overview
    3. | 5.1.2 Competitive Analysis
    4. | 5.1.3 Market share Analysis
    5. | 5.1.4 Major Growth Strategy in the Healthcare
    6. | 5.1.5 Competitive Benchmarking
    7. | 5.1.6 Leading Players in Terms of Number of Developments in the Healthcare
    8. | 5.1.7 Key developments and growth strategies
    9. |-- 5.1.7.1 New Product Launch/Service Deployment
    10. |-- 5.1.7.2 Merger & Acquisitions
    11. |-- 5.1.7.3 Joint Ventures
    12. | 5.1.8 Major Players Financial Matrix
    13. |-- 5.1.8.1 Sales and Operating Income
    14. |-- 5.1.8.2 Major Players R&D Expenditure. 2023
    15. | 5.2 Company Profiles
    16. | 5.2.1 Medtronic (US)
    17. |-- 5.2.1.1 Financial Overview
    18. |-- 5.2.1.2 Products Offered
    19. |-- 5.2.1.3 Key Developments
    20. |-- 5.2.1.4 SWOT Analysis
    21. |-- 5.2.1.5 Key Strategies
    22. | 5.2.2 Johnson & Johnson (US)
    23. |-- 5.2.2.1 Financial Overview
    24. |-- 5.2.2.2 Products Offered
    25. |-- 5.2.2.3 Key Developments
    26. |-- 5.2.2.4 SWOT Analysis
    27. |-- 5.2.2.5 Key Strategies
    28. | 5.2.3 Baxter International (US)
    29. |-- 5.2.3.1 Financial Overview
    30. |-- 5.2.3.2 Products Offered
    31. |-- 5.2.3.3 Key Developments
    32. |-- 5.2.3.4 SWOT Analysis
    33. |-- 5.2.3.5 Key Strategies
    34. | 5.2.4 Boston Scientific (US)
    35. |-- 5.2.4.1 Financial Overview
    36. |-- 5.2.4.2 Products Offered
    37. |-- 5.2.4.3 Key Developments
    38. |-- 5.2.4.4 SWOT Analysis
    39. |-- 5.2.4.5 Key Strategies
    40. | 5.2.5 Stryker (US)
    41. |-- 5.2.5.1 Financial Overview
    42. |-- 5.2.5.2 Products Offered
    43. |-- 5.2.5.3 Key Developments
    44. |-- 5.2.5.4 SWOT Analysis
    45. |-- 5.2.5.5 Key Strategies
    46. | 5.2.6 Abbott Laboratories (US)
    47. |-- 5.2.6.1 Financial Overview
    48. |-- 5.2.6.2 Products Offered
    49. |-- 5.2.6.3 Key Developments
    50. |-- 5.2.6.4 SWOT Analysis
    51. |-- 5.2.6.5 Key Strategies
    52. | 5.2.7 Terumo Corporation (JP)
    53. |-- 5.2.7.1 Financial Overview
    54. |-- 5.2.7.2 Products Offered
    55. |-- 5.2.7.3 Key Developments
    56. |-- 5.2.7.4 SWOT Analysis
    57. |-- 5.2.7.5 Key Strategies
    58. | 5.2.8 Fresenius Medical Care (DE)
    59. |-- 5.2.8.1 Financial Overview
    60. |-- 5.2.8.2 Products Offered
    61. |-- 5.2.8.3 Key Developments
    62. |-- 5.2.8.4 SWOT Analysis
    63. |-- 5.2.8.5 Key Strategies
    64. | 5.2.9 Smith & Nephew (GB)
    65. |-- 5.2.9.1 Financial Overview
    66. |-- 5.2.9.2 Products Offered
    67. |-- 5.2.9.3 Key Developments
    68. |-- 5.2.9.4 SWOT Analysis
    69. |-- 5.2.9.5 Key Strategies
    70. | 5.3 Appendix
    71. | 5.3.1 References
    72. | 5.3.2 Related Reports

Healthcare Market Segmentation

Healthcare By Procedure Type (USD Million, 2025-2035)

  • Open Nephrectomy
  • Laparoscopic Nephrectomy
  • Robotic-Assisted Nephrectomy
  • Partial Nephrectomy

Healthcare By Indication (USD Million, 2025-2035)

  • Renal Cell Carcinoma
  • Kidney Stones
  • Polycystic Kidney Disease
  • Trauma

Healthcare By End User (USD Million, 2025-2035)

  • Hospitals
  • Ambulatory Surgical Centers
  • Specialty Clinics

Healthcare By Surgical Approach (USD Million, 2025-2035)

  • Minimally Invasive Surgery
  • Traditional Surgery
  • Transplant Surgery
Infographic

Free Sample Request

Kindly complete the form below to receive a free sample of this Report

Get Free Sample

Related Reports

Regional Reports
Country Reports

Customer Strories

Customer Stories
Case Study
Aerospace & Defense
Future of Dismounted Soldier Systems Market Trends & Adoption Roadmap 2019–2035

Compare Licence

×
Features License Type
Single User Multiuser License Enterprise User
Price $4,950 $5,950 $7,250
Maximum User Access Limit 1 User Upto 10 Users Unrestricted Access Throughout the Organization
Free Customization ✓ ✓ ✓
Direct Access to Analyst ✓ ✓ ✓
Deliverable Format ✓ ✓ ✓
Platform Access ✗ ✗ ✓
Discount on Next Purchase 10% 15% 15%
Printable Versions ✗ ✗ ✓